AEGLEA BIOTHERAPEUTICS INC (AGLE)
US00773J2024 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -294.44M | -83.82M | -65.80M | -80.89M | -78.25M | |||
| Depreciation Amortization | 1.13M | 1.57M | 1.58M | 1.00M | 420.00K | |||
| Change In Working Capital | -4.49M | -5.50M | 1.83M | -2.54M | 7.10M | |||
| Other non cash items | 210.80M | 7.61M | 8.68M | 6.66M | 5.04M | |||
| OPERATING CASH FLOW | -87.01M | -80.14M | -53.72M | -75.78M | -65.69M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -40.00K | -570.00K | -4.28M | -1.49M | |||
| Other Investing Activity | -59.12M | 57.05M | -22.05M | -3.32M | -250.00K | |||
| INVESTING CASH FLOW | -59.12M | 57.01M | -22.62M | -7.60M | -1.74M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -30.00K | -420.00K | -510.00K | -20.00K | -30.00K | |||
| Stock Issued/Repurchased | 197.49M | 43.10M | 1.90M | 154.53M | 65.75M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 197.46M | 42.68M | 1.39M | 154.51M | 65.72M | |||
| Exchange Rate Effect | 50.00K | -110.00K | -20.00K | 50.00K | N/A | |||
| CHANGE IN CASH | 51.38M | 19.44M | -74.97M | 71.18M | -1.71M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -87.01M | -80.14M | -53.72M | -75.78M | -65.69M | |||
| Capital Expenditure | 0.00 | -40.00K | -570.00K | -4.28M | -1.49M | |||
| FREE CASH FLOW | -87.01M | -80.18M | -54.29M | -80.06M | -67.18M | |||
All data in USD